Else Nutrition Holdings Inc. (OTCMKTS:BABYF – Get Rating) was the recipient of a big decline briefly interest through the month of January. As of January fifteenth, there was short interest totalling 322,500 shares, a decline of 9.2% from the December thirty first total of 355,100 shares. Based on a mean each day volume of 189,300 shares, the days-to-cover ratio is currently 1.7 days.
Analyst Rankings Changes
→ The Next Big Crisis Is Here (From Porter & Company)
Individually, Canaccord Genuity Group decreased their goal price on shares of Else Nutrition from C$2.00 to C$1.50 and set a “buy” rating for the corporate in a research note on Tuesday, November fifteenth.
Else Nutrition Stock Performance
BABYF opened at $0.46 on Friday. The corporate has a fast ratio of 6.81, a current ratio of 8.54 and a debt-to-equity ratio of 0.02. The business has a 50 day moving average of $0.42 and a 200-day moving average of $0.50. Else Nutrition has a 12-month low of $0.30 and a 12-month high of $1.43. The stock has a market cap of $51.24 million and a price-to-earnings ratio of -2.53.
Else Nutrition (OTCMKTS:BABYF – Get Rating) last posted its earnings results on Monday, November 14th. The corporate reported ($0.02) EPS for the quarter. The firm had revenue of $1.71 million through the quarter. Else Nutrition had a negative net margin of 342.93% and a negative return on equity of 110.15%.
About Else Nutrition
(Get Rating)
Else Nutrition Holdings Inc engages in the event, production, and sale of food and nutrition products for infants, toddlers, children, and adults in North America and Israel. It offers baby snacks; baby feeding accessories, resembling feeding bottles and teats; plant-based baby formula products; toddler, children, and adult nutrition products; and complementary food products.
Further Reading
This easy news alert was generated by narrative science technology and financial data from MarketBeat so as to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you concentrate on Else Nutrition, you’ll be wanting to listen to this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a each day basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to purchase now before the broader market catches on… and Else Nutrition wasn’t on the list.
While Else Nutrition currently has a “Buy” rating amongst analysts, top-rated analysts imagine these five stocks are higher buys.
View The Five Stocks Here
